Venture Capital Investing

Health Policy Associates has decades of experience in the biotechnology industry and is able to serve as a valuable bridge between the venture capital community and biotech companies seeking investors.

Trusted in High-Risk FDA Integrity Cases

Chosen for nearly two dozen FDA data-integrity audits.

Audit-Grade Clinical Operations

Built for inspections, not just enrollment.

30+ Years in Complex Devices & Biotech

Decades guiding high‑stakes medtech and biotech programs.

Our broad range of skills – from product development to regulatory compliance – and our relationship with the venture capital community is unique among regulatory and clinical consultants and is a valuable part of our services. We have expertise in performing due diligence as well as contacts and relationships across the industry with extensive medical device experience and knowledge.

We assist investors in the venture capital community evaluating investment opportunities and we provide services to device and biotech companies seeking investors.

Our services for the venture capital community include:

Identifying investment opportunities in a wide array of therapeutic areas
Providing experienced analysis of a company’s regulatory, clinical, and R&D development plans in terms of their responsiveness to regulatory and clinical requirements, market and reimbursement needs, and budgetary needs for development
Assisting in oversight and management of portfolio companies and providing critical guidance on all aspects of a company’s operation (including evaluations of personnel and project performance)

“HPA’s understanding of FDA compliance is light years above everybody else’s.

They work collaboratively with the sites. They can see what’s happening that might be a problem and fix it rather than just documenting it after the fact.”

— Roger Brown

Therapeutic Area Head, Musculoskeletal Repair, Mesoblast

Our services for the device and and biotechnology community include:

Identifying VCs focused on your product’s space, stage, or geographical location, providing effective methods of communications between your company and the VC community, and helping to present your technologies to the appropriate VC firms

Developing credible project plans and timelines which enhance your company’s valuation

Assistance defining and achieving critical milestones which create important evaluation and inflection points to enhance success with venture and private financing

Clarity and Confidence for FDA‑Complex Programs

You can find plenty of partners to run site visits, collect data, or assemble slides.

HPA is different: we are a senior‑led, FDA‑focused team built to help you:

And we do it all with a stable team and predictable budget.

If you’re carrying the pressure of an FDA setback, a critical submission, or a high‑risk trial, you don’t have to navigate it alone.